Answer
The supplied Prismasol 4 mmol/l Potassium passage identifies vitamin D, vitamin D analogues and calcium-containing medicines as potentially increasing hypercalcaemia risk, but does not explain the mechanism.
Sources for this answer
- Prismasol 4 mmol/l Potassium solution for haemodialysis/haemofiltrationVantive Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 6Document updated